Financial Spine Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026 byJosh SandbergJuly 29, 2026
Biologics Financial Spine Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities byJosh SandbergJuly 23, 2026
Spine Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice byTim AllenJuly 22, 2026
Top Stories BONESUPPORT™ Announces Nature Publication Of Pre-Clinical Study Highlighting CERAMENT™’s Attractive Bone Remodeling Properties and as a Local Drug Delivery Platform for Bone Disease byJosh SandbergJune 1, 2016
